Versant Venture Capital VI, L.P. Insider Trading $AKRO Akero Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Versant Venture Capital VI, L.P..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Versant Venture Capital VI, L.P.. Versant Venture Capital VI, L.P. is 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Akero Therapeutics, Inc. ($AKRO) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in Pandion Therapeutics, Inc. ($PAND).

Versant Venture Capital VI, L.P. in Akero Therapeutics, Inc.

Trading Symbol: AKRO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Versant Venture Capital VI, L.P.: 10% Owner
Holdings: 3,129,741 shares
Latest Transaction: Jan 21 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Versant Venture Capital VI, L.P. in Akero Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AKRO, ALGS, BDTX, OYST, PAND

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 21 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	22.39	17,849	399,639	3,092,698	3.1 M to 3.1 M (-0.57 %)
Jan 21 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	21.78	8,091	176,222	3,110,547	3.1 M to 3.1 M (-0.26 %)
Jan 21 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	20.09	11,103	223,059	3,118,638	3.1 M to 3.1 M (-0.35 %)
Jan 21 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	19.72	22,489	443,483	3,129,741	3.2 M to 3.1 M (-0.71 %)
Jan 15 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	19.73	7,511	148,192	3,152,230	3.2 M to 3.2 M (-0.24 %)
Jan 15 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	19.73	7,511	148,192	3,152,230	3.2 M to 3.2 M (-0.24 %)
Jan 15 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	20.00	12,307	246,140	3,159,741	3.2 M to 3.2 M (-0.39 %)
Jan 15 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	20.00	12,307	246,140	3,159,741	3.2 M to 3.2 M (-0.39 %)
Jan 15 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	20.84	83	1,730	3,172,048	3.2 M to 3.2 M (0.00 %)
Jan 15 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	20.84	83	1,730	3,172,048	3.2 M to 3.2 M (0.00 %)
Jan 15 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	20.16	11,593	233,715	3,172,131	3.2 M to 3.2 M (-0.36 %)
Jan 15 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	20.16	11,593	233,715	3,172,131	3.2 M to 3.2 M (-0.36 %)
Jan 15 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	20.10	19,343	388,794	3,183,724	3.2 M to 3.2 M (-0.60 %)
Jan 15 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	20.10	19,343	388,794	3,183,724	3.2 M to 3.2 M (-0.60 %)
Jan 09 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	20.21	16,527	334,011	3,203,067	3.2 M to 3.2 M (-0.51 %)
Jan 09 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	19.80	22,368	442,886	3,219,594	3.2 M to 3.2 M (-0.69 %)
Jan 09 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	20.05	14,162	283,948	3,241,962	3.3 M to 3.2 M (-0.43 %)
Jan 06 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	19.93	42,323	843,497	3,256,124	3.3 M to 3.3 M (-1.28 %)
Jan 06 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	18.32	6,101	111,770	3,298,447	3.3 M to 3.3 M (-0.18 %)
Jan 06 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	17.68	4,968	87,834	3,304,548	3.3 M to 3.3 M (-0.15 %)
Jan 06 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	20.27	100	2,027	3,309,516	3.3 M to 3.3 M (0.00 %)
Jan 06 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	19.18	3,100	59,458	3,309,616	3.3 M to 3.3 M (-0.09 %)
Jan 06 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	J	0.00	11,803	0	0	11.8 K to 0 (-100.00 %)
Jan 06 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Buy	J	0.00	11,803	0	11,803	0 to 11.8 K
Jan 06 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	J	0.00	13,683	0	0	13.7 K to 0 (-100.00 %)
Jan 06 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Buy	J	0.00	13,683	0	13,683	0 to 13.7 K
Jan 06 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	J	0.00	684,143	0	3,312,716	4 M to 3.3 M (-17.12 %)
Jan 06 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	22.17	1,000	22,170	3,996,859	4 M to 4 M (-0.03 %)
Jan 06 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	21.20	3,900	82,680	3,997,859	4 M to 4 M (-0.10 %)
Jan 06 2020	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	19.89	10,952	217,835	4,001,759	4 M to 4 M (-0.27 %)
Dec 31 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	23.48	17,207	404,020	3,656,585	3.7 M to 3.7 M (-0.47 %)
Dec 31 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	24.39	338,919	8,266,234	3,673,792	4 M to 3.7 M (-8.45 %)
Dec 31 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	22.58	33,256	750,920	4,012,711	4 M to 4 M (-0.82 %)
Dec 26 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	22.48	23,600	530,528	4,045,967	4.1 M to 4 M (-0.58 %)
Dec 26 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	21.70	1,605	34,829	4,069,567	4.1 M to 4.1 M (-0.04 %)
Dec 26 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	21.56	5,433	117,135	4,071,172	4.1 M to 4.1 M (-0.13 %)
Dec 26 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	19.80	18,582	367,924	4,076,605	4.1 M to 4.1 M (-0.45 %)
Dec 19 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	19.50	2,020	39,390	4,095,187	4.1 M to 4.1 M (-0.05 %)
Dec 19 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	19.58	7,651	149,807	4,097,207	4.1 M to 4.1 M (-0.19 %)
Dec 19 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	19.50	2,020	39,390	4,095,187	4.1 M to 4.1 M (-0.05 %)
Dec 19 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Sell	S	19.58	7,651	149,807	4,097,207	4.1 M to 4.1 M (-0.19 %)
Jun 25 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Option Exercise	C	0.00	722,737	0	0
Jun 25 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Option Exercise	C	0.00	10,666,667	0	0
Jun 25 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Buy	P	16.00	400,000	6,400,000	4,104,858	3.7 M to 4.1 M (+10.80 %)
Jun 25 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Buy	C	0.00	235,099	0	3,704,858	3.5 M to 3.7 M (+6.78 %)
Jun 25 2019	AKRO	Akero Therapeutics ...	Versant Venture Capital VI, L. ...	10% Owner	Buy	C	0.00	3,469,759	0	3,469,759	0 to 3.5 M

Page: 1